Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes-Gutenberg-University Mainz, Germany.
J Cell Physiol. 2012 Feb;227(2):514-24. doi: 10.1002/jcp.22798.
The hypoxia-inducible factor-1 (HIF-1) is an oxygen-regulated transcriptional activator playing a pivotal role in mammalian physiology and disease pathogenesis, e.g., HIF-1 is indispensable in a broad range of developmental stages in different tumors. Its post-translational regulation via PHDs under the influence of hypoxia is widely investigated and accepted. Different non-hypoxic stimuli such as lipopolysaccharides (LPS), thrombin, and angiotensin II (Ang II), have been proven to enhance HIF-1 levels through activation of regulative mechanisms distinct from protein stabilization. Some of these stimuli specifically regulate HIF-1α at the transcriptional, post-transcriptional, or translational level, whereas others additionally influence post-translational modifications. Thus, it is difficult for the investigators to discern the impact of the different mechanisms leading to functional HIF-1 protein. Nevertheless, profound knowledge of additional regulatory networks appears to depict new therapeutic opportunities and thus is an interesting and important field for further investigations.
缺氧诱导因子-1(HIF-1)是一种氧调节转录激活因子,在哺乳动物生理学和疾病发病机制中发挥着关键作用,例如,HIF-1 在不同肿瘤的广泛发育阶段是不可或缺的。其在缺氧影响下通过 PHDs 的翻译后调节已被广泛研究和接受。不同的非缺氧刺激物,如脂多糖(LPS)、凝血酶和血管紧张素 II(Ang II),已被证明通过不同于蛋白稳定的调节机制增强 HIF-1 水平。其中一些刺激物专门在转录、转录后或翻译水平调节 HIF-1α,而其他刺激物则另外影响翻译后修饰。因此,研究人员很难区分导致功能性 HIF-1 蛋白的不同机制的影响。然而,对其他调节网络的深入了解似乎描绘了新的治疗机会,因此是进一步研究的一个有趣且重要的领域。